HERPES SIMPLEX 2
Clinical trials for HERPES SIMPLEX 2 explained in plain language.
Never miss a new study
Get alerted when new HERPES SIMPLEX 2 trials appear
Sign up with your email to follow new studies for HERPES SIMPLEX 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common cold sore drug slow memory loss?
Disease control CompletedThis study tested whether a common antiviral drug, valacyclovir, can slow memory decline in people with mild cognitive impairment (MCI) who also carry the herpes simplex virus. Fifty adults aged 50-95 with MCI and positive for herpes antibodies took either the drug or a placebo f…
Matched conditions: HERPES SIMPLEX 2
Phase: PHASE2 • Sponsor: New York State Psychiatric Institute • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Common cold sore drug tested as potential Alzheimer's slowing treatment
Disease control CompletedThis study investigated whether a high dose of the common antiviral drug valacyclovir (Valtrex), used to treat herpes, could slow the progression of Alzheimer's disease. It involved 120 people with mild Alzheimer's who also tested positive for herpes simplex virus. Participants t…
Matched conditions: HERPES SIMPLEX 2
Phase: PHASE2 • Sponsor: Columbia University • Aim: Disease control
Last updated Apr 13, 2026 20:21 UTC